Medtronic MDT Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, And Equity Method Investments
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments.
The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's equity securities, fv-ni, equity securities without readily determinable fair value, and equity method investments.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's equity securities, FV-NI, equity securities without readily determinable fair value, and equity method investments?
- Medtronic (MDT) reported equity securities, FV-NI, equity securities without readily determinable fair value, and equity method investments of $1B in Q4 2025.
- How has Medtronic's equity securities, FV-NI, equity securities without readily determinable fair value, and equity method investments changed year-over-year?
- Medtronic's equity securities, FV-NI, equity securities without readily determinable fair value, and equity method investments decreased by 18.5% year-over-year, from $1.23B to $1B.